• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nef功能受损与HIV-1病毒血症的早期控制相关。

Impaired Nef function is associated with early control of HIV-1 viremia.

作者信息

Kuang Xiaomei T, Li Xiaoguang, Anmole Gursev, Mwimanzi Philip, Shahid Aniqa, Le Anh Q, Chong Louise, Qian Hua, Miura Toshiyuki, Markle Tristan, Baraki Bemuluyigza, Connick Elizabeth, Daar Eric S, Jessen Heiko, Kelleher Anthony D, Little Susan, Markowitz Martin, Pereyra Florencia, Rosenberg Eric S, Walker Bruce D, Ueno Takamasa, Brumme Zabrina L, Brockman Mark A

机构信息

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.

Center for AIDS Research, Kumamoto University, Kumamoto, Japan.

出版信息

J Virol. 2014 Sep 1;88(17):10200-13. doi: 10.1128/JVI.01334-14. Epub 2014 Jun 25.

DOI:10.1128/JVI.01334-14
PMID:24965469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4136354/
Abstract

UNLABELLED

Host and viral factors influence the HIV-1 infection course. Reduced Nef function has been observed in HIV-1 controllers during the chronic phase, but the kinetics and mechanisms of Nef attenuation in such individuals remain unclear. We examined plasma RNA-derived Nef clones from 10 recently infected individuals who subsequently suppressed viremia to less than 2,000 RNA copies/ml within 1 year postinfection (acute controllers) and 50 recently infected individuals who did not control viremia (acute progressors). Nef clones from acute controllers displayed a lesser ability to downregulate CD4 and HLA class I from the cell surface and a reduced ability to enhance virion infectivity compared to those from acute progressors (all P<0.01). HLA class I downregulation activity correlated inversely with days postinfection (Spearman's R=-0.85, P=0.004) and positively with baseline plasma viral load (Spearman's R=0.81, P=0.007) in acute controllers but not in acute progressors. Nef polymorphisms associated with functional changes over time were identified in follow-up samples from six controllers. For one such individual, mutational analyses indicated that four polymorphisms selected by HLA-A31 and B37 acted in combination to reduce Nef steady-state protein levels and HLA class I downregulation activity. Our results demonstrate that relative control of initial HIV-1 viremia is associated with Nef clones that display reduced function, which in turn may influence the course of HIV-1 infection. Transmission of impaired Nef sequences likely contributed in part to this observation; however, accumulation of HLA-associated polymorphisms in Nef that impair function also suggests that CD8+ T-cell pressures play a role in this phenomenon.

IMPORTANCE

Rare individuals can spontaneously control HIV-1 viremia in the absence of antiretroviral treatment. Understanding the host and viral factors that contribute to the controller phenotype may identify new strategies to design effective vaccines or therapeutics. The HIV-1 Nef protein enhances viral pathogenesis through multiple mechanisms. We examined the function of plasma HIV-1 RNA-derived Nef clones isolated from 10 recently infected individuals who subsequently controlled HIV viremia compared to the function of those from 50 individuals who failed to control viremia. Our results demonstrate that early Nef clones from HIV controllers displayed lower HLA class I and CD4 downregulation activity, as well as a reduced ability to enhance virion infectivity. The accumulation of HLA-associated polymorphisms in Nef during the first year postinfection was associated with impaired protein function in some controllers. This report highlights the potential for host immune responses to modulate HIV pathogenicity and disease outcome by targeting cytotoxic T lymphocyte (CTL) epitopes in Nef.

摘要

未标记

宿主和病毒因素会影响HIV-1感染进程。在慢性期的HIV-1病毒控制者中已观察到Nef功能降低,但这些个体中Nef衰减的动力学和机制仍不清楚。我们检测了10名近期感染个体的血浆RNA衍生的Nef克隆,这些个体在感染后1年内病毒血症抑制至低于2000 RNA拷贝/毫升(急性控制者),以及50名未控制病毒血症的近期感染个体(急性进展者)。与急性进展者相比,急性控制者的Nef克隆下调细胞表面CD4和I类HLA的能力较弱,增强病毒体感染性的能力也较低(所有P<0.01)。在急性控制者中,I类HLA下调活性与感染后天数呈负相关(斯皮尔曼相关系数R=-0.85,P=0.004),与基线血浆病毒载量呈正相关(斯皮尔曼相关系数R=0.81,P=0.007),而在急性进展者中则不然。在6名控制者的随访样本中鉴定出与功能随时间变化相关的Nef多态性。对于其中一名个体,突变分析表明,由HLA-A31和B37选择的四个多态性共同作用,降低了Nef稳态蛋白水平和I类HLA下调活性。我们的结果表明,对初始HIV-1病毒血症的相对控制与功能降低的Nef克隆相关,这反过来可能影响HIV-1感染进程。受损Nef序列的传播可能部分导致了这一观察结果;然而,Nef中与HLA相关的损害功能的多态性积累也表明CD8+T细胞压力在这一现象中起作用。

重要性

少数个体在无抗逆转录病毒治疗的情况下可自发控制HIV-1病毒血症。了解促成控制者表型的宿主和病毒因素可能会确定设计有效疫苗或治疗方法的新策略。HIV-1 Nef蛋白通过多种机制增强病毒致病性。我们检测了从10名近期感染个体中分离的血浆HIV-1 RNA衍生的Nef克隆的功能,这些个体随后控制了HIV病毒血症,并将其与50名未控制病毒血症个体的Nef克隆功能进行了比较。我们的结果表明,HIV控制者的早期Nef克隆显示出较低的I类HLA和CD4下调活性,以及增强病毒体感染性的能力降低。感染后第一年Nef中与HLA相关的多态性积累与一些控制者的蛋白功能受损有关。本报告强调了宿主免疫反应通过靶向Nef中的细胞毒性T淋巴细胞(CTL)表位来调节HIV致病性和疾病结局的潜力。

相似文献

1
Impaired Nef function is associated with early control of HIV-1 viremia.Nef功能受损与HIV-1病毒血症的早期控制相关。
J Virol. 2014 Sep 1;88(17):10200-13. doi: 10.1128/JVI.01334-14. Epub 2014 Jun 25.
2
Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.原发性HIV-1 Nef分离株下调HIV-1进入受体的差异能力。
J Virol. 2015 Sep;89(18):9639-52. doi: 10.1128/JVI.01548-15. Epub 2015 Jul 15.
3
Attenuation of multiple Nef functions in HIV-1 elite controllers.HIV-1 精英控制者中多种 Nef 功能的衰减。
Retrovirology. 2013 Jan 7;10:1. doi: 10.1186/1742-4690-10-1.
4
Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.天然 HIV-1 Nef 多态性削弱 SERINC5 的下调活性。
Cell Rep. 2019 Nov 5;29(6):1449-1457.e5. doi: 10.1016/j.celrep.2019.10.007.
5
HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.HIV 亚型和 Nef 介导的免疫逃逸功能与早期治疗个体中的病毒储存库大小相关。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01832-18. Print 2019 Mar 15.
6
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.HIV-1 Nef 下调 CD4 和 HLA Ⅰ类分子的能力在不同病毒亚型间存在差异。
Retrovirology. 2013 Sep 16;10:100. doi: 10.1186/1742-4690-10-100.
7
Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.HIV-1 Vif蛋白的抗载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)活性在精英控制者中减弱。
J Virol. 2015 May;89(9):4992-5001. doi: 10.1128/JVI.03464-14. Epub 2015 Feb 25.
8
Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.相对于主要组织相容性复合体A类(MHC-A),主要组织相容性复合体B类(MHC-B)对Nef介导的下调的抗性在灵长类慢病毒中是保守的,并影响HIV-1感染个体的抗病毒T细胞反应。
J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01409-17. Print 2018 Jan 1.
9
Impaired replication capacity of acute/early viruses in persons who become HIV controllers.急性/早期病毒复制能力受损的人成为 HIV 控制器。
J Virol. 2010 Aug;84(15):7581-91. doi: 10.1128/JVI.00286-10. Epub 2010 May 26.
10
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.HLA-B*13相关逃逸突变对HIV-1复制及Nef功能的影响
J Virol. 2015 Nov;89(22):11557-71. doi: 10.1128/JVI.01955-15. Epub 2015 Sep 9.

引用本文的文献

1
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.在急性至慢性HIV-1感染过程中,Nef在拮抗SERINC5方面的功能变异性。
AIDS. 2025 Mar 1;39(3):229-240. doi: 10.1097/QAD.0000000000004079. Epub 2024 Dec 4.
2
No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated.在疫情起源地喀麦隆流行的HIV-1 M组谱系中,Nef介导的HLA-I和CD4分子下调没有可检测到的差异。
Front Virol. 2024 May 29;4. doi: 10.3389/fviro.2024.1379217.
3
Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics.机器学习支持D1、Nef和Tat影响HIV储存库动态的证据。
Pathog Immun. 2024 Jan 23;8(2):37-58. doi: 10.20411/pai.v8i2.621. eCollection 2023.
4
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.Nef 拮抗 SERINC5 的能力受损与 HIV 感染者血浆病毒血症降低有关。
Sci Rep. 2020 Nov 10;10(1):19416. doi: 10.1038/s41598-020-76375-w.
5
Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5.HIV-1 Nef 功能在病毒亚型内和之间的变化揭示了 SERINC3 和 SERINC5 的遗传可分离拮抗作用。
PLoS Pathog. 2020 Sep 14;16(9):e1008813. doi: 10.1371/journal.ppat.1008813. eCollection 2020 Sep.
6
Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study.HIV Nef 介导的 CD4、HLA 和 SERINC5 下调活性的宿主内纵向进化:案例研究。
Retrovirology. 2020 Jan 9;17(1):3. doi: 10.1186/s12977-019-0510-1.
7
Modelling and testing of the HIV-1 Nef fitness landscape.HIV-1 Nef适应性景观的建模与测试
Virus Evol. 2019 Aug 5;5(2):vez029. doi: 10.1093/ve/vez029. eCollection 2019 Jul.
8
Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.Nef 介导的 TCR 刺激后 NFAT 的抑制作用在 HIV-1 亚型之间存在差异。
Virology. 2019 May;531:192-202. doi: 10.1016/j.virol.2019.02.011. Epub 2019 Feb 21.
9
HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.HIV 亚型和 Nef 介导的免疫逃逸功能与早期治疗个体中的病毒储存库大小相关。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01832-18. Print 2019 Mar 15.
10
HIV control: Is getting there the same as staying there?艾滋病毒控制:到达终点是否等同于保持在终点?
PLoS Pathog. 2018 Nov 1;14(11):e1007222. doi: 10.1371/journal.ppat.1007222. eCollection 2018 Nov.

本文引用的文献

1
Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective.HIV-1 感染的毒力和发病机制:一种进化角度的研究。
Science. 2014 Mar 21;343(6177):1243727. doi: 10.1126/science.1243727.
2
How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4.HIV-1 Nef如何劫持AP-2网格蛋白衔接蛋白以下调CD4。
Elife. 2014;3:e01754. doi: 10.7554/eLife.01754. Epub 2014 Jan 28.
3
Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.HIV 特异性 CD8+ T 细胞反应的幅度、多功能能力和特异性对 HIV 定殖点的差异化影响。
J Virol. 2014 Feb;88(3):1819-24. doi: 10.1128/JVI.02968-13. Epub 2013 Nov 13.
4
HIV-1 Nef and T-cell activation: a history of contradictions.HIV-1 Nef与T细胞活化:一段矛盾的历史。
Future Virol. 2013 Apr 1;8(4). doi: 10.2217/fvl.13.20.
5
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.HIV-1 Nef 下调 CD4 和 HLA Ⅰ类分子的能力在不同病毒亚型间存在差异。
Retrovirology. 2013 Sep 16;10:100. doi: 10.1186/1742-4690-10-100.
6
Nef-specific CD8+ T cell responses contribute to HIV-1 immune control.Nef 特异性 CD8+ T 细胞应答有助于 HIV-1 的免疫控制。
PLoS One. 2013 Sep 2;8(9):e73117. doi: 10.1371/journal.pone.0073117. eCollection 2013.
7
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.6300 例感染病例和 7200 例对照的常见遗传变异与 HIV-1 获得的关联研究。
PLoS Pathog. 2013;9(7):e1003515. doi: 10.1371/journal.ppat.1003515. Epub 2013 Jul 25.
8
Extreme genetic fragility of the HIV-1 capsid.HIV-1 衣壳的极端遗传脆弱性。
PLoS Pathog. 2013;9(6):e1003461. doi: 10.1371/journal.ppat.1003461. Epub 2013 Jun 20.
9
Dynamic range of Nef functions in chronic HIV-1 infection.慢性 HIV-1 感染中 Nef 功能的动态范围。
Virology. 2013 May 10;439(2):74-80. doi: 10.1016/j.virol.2013.02.005. Epub 2013 Mar 13.
10
HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.HIV-1 保守元件疫苗:序列保守性与复制能力的关系。
J Virol. 2013 May;87(10):5461-7. doi: 10.1128/JVI.03033-12. Epub 2013 Mar 6.